These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17699259)

  • 1. Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation.
    Ueda M; O'Brien K; Rosing DR; Ling A; Kleta R; McAreavey D; Bernardini I; Gahl WA
    Clin J Am Soc Nephrol; 2006 May; 1(3):555-62. PubMed ID: 17699259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of cystinosis: mechanisms beyond cystine accumulation.
    Wilmer MJ; Emma F; Levtchenko EN
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F905-16. PubMed ID: 20826575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From gene to disease: cystinosis].
    Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.
    Andrzejewska Z; Nevo N; Thomas L; Chhuon C; Bailleux A; Chauvet V; Courtoy PJ; Chol M; Guerrera IC; Antignac C
    J Am Soc Nephrol; 2016 Jun; 27(6):1678-88. PubMed ID: 26449607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystinosis: a review.
    Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
    Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystinosis: clinical presentation, pathogenesis and treatment.
    Ivanova E; De Leo MG; De Matteis MA; Levtchenko E
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():176-84. PubMed ID: 25345100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystinosis].
    Watanabe H; Kamoshita S
    Nihon Rinsho; 1992 Jul; 50(7):1593-8. PubMed ID: 1404889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal complications of cystinosis.
    Topaloglu R
    Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FISH diagnosis of the common 57-kb deletion in CTNS causing cystinosis.
    Bendavid C; Kleta R; Long R; Ouspenskaia M; Muenke M; Haddad BR; Gahl WA
    Hum Genet; 2004 Nov; 115(6):510-4. PubMed ID: 15365816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of nephropathic cystinosis with cysteamine.
    Kleta R; Gahl WA
    Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.
    Levtchenko EN; van Dael CM; de Graaf-Hess AC; Wilmer MJ; van den Heuvel LP; Monnens LA; Blom HJ
    Pediatr Nephrol; 2006 Jan; 21(1):110-3. PubMed ID: 16252107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal transplantation on coronary artery calcification in hemodialysis patients.
    Abedi SA; Tarzamni MK; Nakhjavani MR; Bohlooli A
    Transplant Proc; 2009 Sep; 41(7):2829-31. PubMed ID: 19765448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
    Sonies BC; Almajid P; Kleta R; Bernardini I; Gahl WA
    Medicine (Baltimore); 2005 May; 84(3):137-146. PubMed ID: 15879904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early oral cysteamine therapy for nephropathic cystinosis.
    Gahl WA
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S38-41. PubMed ID: 14610675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
    Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
    Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.